Progressive Multiple Sclerosis (PMS)

Neurology·MeSH: Autoimmune Diseases

Prevalence

120.0 / 100K

Incidence

7.0 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Progressive Multiple Sclerosis (PMS)?

There are 1 clinical trial targeting Progressive Multiple Sclerosis (PMS) tracked by BioSniper.

What is the prevalence of Progressive Multiple Sclerosis (PMS)?

The estimated prevalence of Progressive Multiple Sclerosis (PMS) is approximately 120.0 per 100,000 population.

Deep-dive into Progressive Multiple Sclerosis (PMS)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Progressive Multiple Sclerosis (PMS) — Drugs in Development & Clinical Trials | BioSniper